510(k) Report

510(k) · Cleared

Recalled · Class I · 2013

Freestyle Insulinx Blood Glucose Monitoring System

K120568510(k) SpecialCleared Mar 29, 201231-day reviewClass II21 CFR 862.1345Recalls 1 (1 Class I)

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Diabetes Care, Inc. · NBW System, Test, Blood Glucose, Over The Counter

Cleared on Mar 29, 2012 as substantially equivalent to K111874 (Abbott Laboratories, 2012) after a 31-day review. Its family tree reaches back 6 generations to 1995. 1 of the 18 devices in its family, counting itself, has a Class I recall. 1 later device descends from it. It has been recalled once, including a Class I recall.

Decided
Mar 29, 2012
Review
31 days
Class
Class II
Product code
NBW
Recalls
1 (1 Class I)
Predicates
1

Its longest line of descent runs back 6 generations to K945887 (1995). 16 ancestors in all, the oldest K922888 (1992). 1 later device descends from it, 1 citing it directly. 1 of the 18 devices in this family, counting this one, has a Class I recall.

  1. Root · 6 generations backK945887 Precision Q I D Blood Glucose Test StripsMedisense, Inc. · 1995
  2. 5 generations backK970707 Elect II Blood Glucose Monitoring SystemSelfcare, Inc. · 1997
  3. 4 generations backK992684 Freestyle Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2000 · Recalled
  4. 3 generations backK012014 Modification to Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2001
  5. 2 generations backK020866 Freestyle Tracker Diabetes Management SystemAbbott Diabetes Care, Inc. · 2002
  6. 1 generation backK111874 Freestyle Insulinx Blood Glucose Monitoring SystemsAbbott Laboratories · 2012
  7. This deviceK120568 Freestyle Insulinx Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc. · 2012
  8. Descendant · cites it directly · 0 of its ownK152328 FreeStyle InsuLinx Blood Glucose Monotioring SystemAbott Laboratories · 2015

Most influential descendants

Showing 1 of 1 · See all
  • K152328FreeStyle InsuLinx Blood Glucose Monotioring SystemAbott Laboratories · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K945887Precision Q I D Blood Glucose Test StripsMedisense, Inc.1995—
−5K970707Elect II Blood Glucose Monitoring SystemSelfcare, Inc.1997—
−4K992684Freestyle Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.20002
−3K012014Modification to Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.2001—
−2K020866Freestyle Tracker Diabetes Management SystemAbbott Diabetes Care, Inc.2002—
−1K111874Freestyle Insulinx Blood Glucose Monitoring SystemsAbbott Laboratories2012—
0 (this device)K120568Freestyle Insulinx Blood Glucose Monitoring SystemAbbott Diabetes Care, Inc.2012—
+1K152328FreeStyle InsuLinx Blood Glucose Monotioring SystemAbott Laboratories2015—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199220
199310
199510
199610
199830
200020

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K120568, 1995–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NBW device

  1. #1 K260545 CONTOUR® PLUS BLUE Blood Glucose Monitoring…score 14.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K111874Freestyle Insulinx Blood Glucose Monitoring Systems
Summary page 5
…Insutinx Blood Modified FreeStjle InsutLinx Glucose Monitoring System, Blood Glucose Monitoring ______________(k111874) FSystem CHARACTERISTICS Indications for Use The FreeStyle lnsuLinx Blood Same…
Abbott Laboratories2012—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K152328FreeStyle InsuLinx Blood Glucose Monotioring SystemAbott Laboratories20150

Has anything in its family been recalled? (1 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 15, 2013Class IZ-1245-2013Software designAT rare, extremely high glucose levels (1024 mg/dL and above), the FreeStyle InsuLinx Blood Glucose Meter may provide an inaccurate reading.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 4 companies; a new generation was cleared every 2.2 years on median.
  • 4 of the 16 ancestors have a recall of any class.
  • Of its descendants, K152328 (Abott Laboratories, 2015) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NBW devices

NBW System, Test, Blood Glucose, Over The Counter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · NBW

2in 2025

2007: 292008: 372009: 382010: 312011: 302012: 302013: 472014: 242015: 322016: 202017: 252018: 192019: 102020: 72021: 72022: 122023: 52024: 72025: 22026 (partial year): 5
2007high 47 (2013) · low 2 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NBW

243in 2024

2007: 85 days median2008: 128 days median2009: 140 days median2010: 132 days median2011: 328 days median2012: 230 days median2013: 167 days median2014: 202 days median2015: 237 days median2016: 233 days median2017: 244 days median2018: 168 days median2019: 127 days median2020: 121 days median2021: 465 days median2022: 410 days median2023: 193 days median2024: 243 days median2026 (partial year): 190 days median
2007high 465 (2021) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NBW

1in 2025

2007: 92008: 22009: 52010: 112011: 12012: 12013: 5, 2 Class I2014: 12016: 12019: 142025: 1
2007high 14 (2019) · low 0 (2015)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · NBW

4,745in 2025

2007: 7,9912008: 7,7042009: 10,9632010: 11,6312011: 22,9092012: 23,4492013: 35,4082014: 38,5242015: 62,1112016: 76,6212017: 37,5382018: 16,9112019: 14,4722020: 10,7032021: 9,1982022: 8,1032023: 7,2562024: 6,2202025: 4,745
2007high 76,621 (2016) · low 4,745 (2025)2025

MAUDE reports naming product code NBW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007298597,991
20083712827,704
200938140510,963
2010311321111,631
201130328122,909
201230230123,449
2013471675 (2)35,408
201424202138,524
201532237062,111
201620233176,621
201725244037,538
201819168016,911
2019101271414,472
20207121010,703
2021746509,198
20221241008,103
2023519307,256
2024724306,220
20252—14,745
202651900—

What is it indicated for?

The FreeStyle InsuL-inx Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip. The FreeStyle InsuLinx Blood Glucose Monitoring System is intended to be used by a single person and should not be shared. The FreeStyle InsuLinx Blood Glucose Monitoring System is intended for self testing outside the body (in vitro diagnostic use) by people with diabetes at home…

Read the full statement (134 words)

The FreeStyle InsuL-inx Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip. The FreeStyle InsuLinx Blood Glucose Monitoring System is intended to be used by a single person and should not be shared.

The FreeStyle InsuLinx Blood Glucose Monitoring System is intended for self testing outside the body (in vitro diagnostic use) by people with diabetes at home as an aid to monitor the effectiveness of diabetes control. The FreeStyle InsuLinx Blood Glucose Monitoring System should not be used for the diagnosis of or screening for diabetes or for neonatal use.

The FreeStyle lnsuLinx Blood Glucose Test Strips are for use with the FreeStyle lnsuLinx Blood Glucose Meter to quantitatively measure glucose in capillary whole blood samples drawn from the fingertip.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K120568: Freestyle Insulinx Blood Glucose Monitoring System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K120568

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026